Startup iBinom Launches Beta Version of Flagship Genomic Data Interpretation Software | GenomeWeb

Russian bioinformatics firm iBinom has released a beta version of a data interpretation solution that bears the company name and is designed for analyzing whole-genome, whole-exome, and targeted sequencing data in clinical contexts.

The company designed the software-as-a-service solution, it said, to provide clinical researchers who are studying inherited diseases in medical centers, academia, and so on, with a tool to rapidly identify known pathogenic mutations in their data and was simple enough for users without informatics expertise to operate.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.